{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Melville",
      "state": "NY",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "76611",
      "recalling_firm": "Fougera Pharmaceuticals  Inc.",
      "address_1": "60 Baylis Rd",
      "address_2": "",
      "postal_code": "11747-3838",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-0612-2017",
      "product_description": "Desonide Ointment, 0.05%, NET WT 60 grams tubes, Rx only, E. FOUGERA & CO.  A division of Fougera Pharmaceuticals Inc., Melville, New York 11747, NDC 0168-0309-60",
      "product_quantity": "14,665 tubes",
      "reason_for_recall": "Labeling: Label Mixup; Unit boxes labeled as Desonide Ointment 0.05% may contain tubes of Desonide Ointment labeled as Ketoconazole Cream",
      "recall_initiation_date": "20170302",
      "center_classification_date": "20170323",
      "termination_date": "20180702",
      "report_date": "20170329",
      "code_info": "Lot GC9231 (exp. 05/2019); Lot GC9232 (exp. 05/2019)",
      "more_code_info": ""
    }
  ]
}